Figure 4
From: Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer
ChemoRT upregulates Smurf2 protein expression in tumor cells in patients with stage III NSCLC. Smurf2 IHC revealed significantly higher Smurf2 protein expression in the post-chemoRT-patient lung tumor samples (n = 8) than in the pre-chemoRT tumor samples (n = 7). Representative examples are shown.
